Automated normalization of multiplex imaging replaces manual methods to reduce variability, enabling biopharma researchers to accurately identify novel spatial biomarkers and scale up biomarker ...

Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), licensed its ADC technology to BigHat Biosciences ...

Turbine and AstraZeneca have entered a partnership to enhance the discovery of antibody-drug conjugates (ADCs) using the ...

ADC stands for automatic defect classification. It’s a software that classifies defects based on image and metadata such as location, ROI, and other information associated with a defect. ADC is not a ...

CHICAGO--(BUSINESS WIRE)--Nucleai, an AI-powered spatial biomarker and diagnostics company, today announced the launch of its deep learning model that automates the normalization of high-plex imaging ...